Healthcare Industry Reports

Reports > Healthcare > Selected Report

North America Cytotoxic Drug Market Report for Period 2017 till 2022

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic and ‘cytotoxic are often used interchangeably.


Scope of the Report
This report focuses on the Cytotoxic Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Roche
Eli Lilly
Celgene
Sanofi
eisai
Sumitomo Dainippon Pharma
Merck
Seattle Genetics
Takeda
Haosoh Pharma
Novartis
AstraZeneca
Jazz Pharma
Spectrum Pharma

Market Segment by Countries, covering
United States
Canada
Mexico

Market Segment by Type, covers
Injection
Solid Oral Dose Forms
Others

Market Segment by Applications, can be divided into
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other

There are 15 Chapters to deeply display the North America Cytotoxic Drug market.

Chapter 1, to describe Cytotoxic Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Cytotoxic Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Cytotoxic Drug, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Cytotoxic Drug market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Cytotoxic Drug Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Cytotoxic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Solid Oral Dose Forms
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Breast Cancer
1.3.2 Blood Cancer
1.3.3 Prostate Cancer
1.3.4 Respiratory/Lung Cancer
1.3.5 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Profile
2.1.2 Cytotoxic Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Roche News
2.2 Eli Lilly
2.2.1 Profile
2.2.2 Cytotoxic Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Eli Lilly Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Eli Lilly News
2.3 Celgene
2.3.1 Profile
2.3.2 Cytotoxic Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Celgene Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Celgene News
2.4 Sanofi
2.4.1 Profile
2.4.2 Cytotoxic Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sanofi Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Sanofi News
2.5 eisai
2.5.1 Profile
2.5.2 Cytotoxic Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 eisai Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 eisai News
2.6 Sumitomo Dainippon Pharma
2.6.1 Profile
2.6.2 Cytotoxic Drug Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Sumitomo Dainippon Pharma News
2.7 Merck
2.7.1 Profile
2.7.2 Cytotoxic Drug Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Merck Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Merck News
2.8 Seattle Genetics
2.8.1 Profile
2.8.2 Cytotoxic Drug Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Seattle Genetics Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Seattle Genetics News
2.9 Takeda
2.9.1 Profile
2.9.2 Cytotoxic Drug Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Takeda Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Takeda News
2.10 Haosoh Pharma
2.10.1 Profile
2.10.2 Cytotoxic Drug Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Haosoh Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Haosoh Pharma News
2.11 Novartis
2.11.1 Profile
2.11.2 Cytotoxic Drug Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Novartis Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Novartis News
2.12 AstraZeneca
2.12.1 Profile
2.12.2 Cytotoxic Drug Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 AstraZeneca Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 AstraZeneca News
2.13 Jazz Pharma
2.13.1 Profile
2.13.2 Cytotoxic Drug Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Jazz Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 Jazz Pharma News
2.14 Spectrum Pharma
2.14.1 Profile
2.14.2 Cytotoxic Drug Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Spectrum Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14.4 Business Overview
2.14.5 Spectrum Pharma News
3 North America Cytotoxic Drug Market Competition, by Manufacturer
3.1 North America Cytotoxic Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Cytotoxic Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Cytotoxic Drug Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Cytotoxic Drug Manufacturer Market Share
3.4.2 Top 5 Cytotoxic Drug Manufacturer Market Share
3.5 Market Competition Trend
4 North America Cytotoxic Drug Market Analysis by Countries
4.1 North America Cytotoxic Drug Sales Market Share by Countries
4.2 North America Cytotoxic Drug Sales by Countries (2012-2017)
4.3 North America Cytotoxic Drug Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Cytotoxic Drug by Type
5.1 North America Cytotoxic Drug Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Cytotoxic Drug Sales and Market Share by Type (2012-2017)
5.1.2 North America Cytotoxic Drug Revenue and Market Share by Type (2012-2017)
5.2 Injection Sales Growth and Price
5.2.1 North America Injection Sales Growth (2012-2017)
5.2.2 North America Injection Price (2012-2017)
5.3 Solid Oral Dose Forms Sales Growth and Price
5.3.1 North America Solid Oral Dose Forms Sales Growth (2012-2017)
5.3.2 North America Solid Oral Dose Forms Price (2012-2017)
5.4 Others Sales Growth and Price
5.4.1 North America Others Sales Growth (2012-2017)
5.4.2 North America Others Price (2012-2017)
6 North America Market Segmentation Cytotoxic Drug by Application
6.1 North America Cytotoxic Drug Sales Market Share by Application (2012-2017)
6.2 Breast Cancer Sales Growth (2012-2017)
6.3 Blood Cancer Sales Growth (2012-2017)
6.4 Prostate Cancer Sales Growth (2012-2017)
6.5 Respiratory/Lung Cancer Sales Growth (2012-2017)
6.6 Other Sales Growth (2012-2017)
7 United States Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Cytotoxic Drug Sales and Market Share by Type
7.3 United States Cytotoxic Drug Sales by Application (2012-2017)
7.4 United States Cytotoxic Drug Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Cytotoxic Drug Sales and Market Share by Manufacturer
7.4.2 United States Cytotoxic Drug Revenue and Market Share by Manufacturer
7.5 United States Cytotoxic Drug Export and Import (2012-2017)
8 Canada Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Cytotoxic Drug Sales and Market Share by Type
8.3 Canada Cytotoxic Drug Sales by Application (2012-2017)
8.4 Canada Cytotoxic Drug Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Cytotoxic Drug Sales and Market Share by Manufacturer
8.4.2 Canada Cytotoxic Drug Revenue and Market Share by Manufacturer
8.5 Canada Cytotoxic Drug Export and Import (2012-2017)
9 Mexico Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Cytotoxic Drug Sales and Market Share by Type
9.3 Mexico Cytotoxic Drug Sales by Application (2012-2017)
9.4 Mexico Cytotoxic Drug Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Cytotoxic Drug Sales and Market Share by Manufacturer
9.4.2 Mexico Cytotoxic Drug Revenue and Market Share by Manufacturer
9.5 Mexico Cytotoxic Drug Export and Import (2012-2017)
10 Cytotoxic Drug Market Forecast (2017-2022)
10.1 North America Cytotoxic Drug Sales, Revenue and Growth Rate (2017-2022)
10.2 Cytotoxic Drug Market Forecast by Countries (2017-2022)
10.2.1 United States Cytotoxic Drug Forecast (2017-2022)
10.2.2 Canada Cytotoxic Drug Forecast (2017-2022)
10.2.3 Mexico Cytotoxic Drug Forecast (2017-2022)
10.3 Cytotoxic Drug Market Forecast by Type (2017-2022)
10.4 Cytotoxic Drug Market Forecast by Application (2017-2022)
11 Cytotoxic Drug Manufacturing Cost Analysis
11.1 Cytotoxic Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cytotoxic Drug
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cytotoxic Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cytotoxic Drug Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

â–  Press releases, annual reports, Non-Profit organizations
â–  Industry associations, governmental agencies and customs data
â–  Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

â–  Product manufacturers
â–  Opinion leaders, industry experts and research institutions
â–  Distributors, Dealer and Traders
â–  Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 34217

Category: 11

Published date: 2017-10-04 19:13:01

Number of Pages: 116

Publisher Name: GIR

Over all Rating: 83 % (Average of Ratings provided by clients)